$86.05 1.4%
AXSM Stock Price vs. AI Score
Data gathered: July 23

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Axsome Therapeutics

Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States.

Axsome Therapeutics
Price $86.05
Target Price Sign up
Volume 527,650
Market Cap $4.03B
Year Range $59.18 - $97.64
Dividend Yield 0%
Earnings Date August 5 '24
Industry Biotechnology

In the news

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '2469M107M-38M-68M-61M-1.440
Q4 '2366M96M-30M-99M-92M-2.080
Q3 '2353M91M-39M-62M-56M-1.320
Q2 '2347M85M-43M-67M-62M-1.540
Q1 '2395M83M6.8M-11M-2.6M-0.260

Insider Transactions View All

Coleman Mark filed to sell 14,600 shares at $75.1.
May 29 '24
Jacobson Mark L. filed to sell 5,783 shares at $74.3.
May 29 '24
Coleman Mark filed to sell 19,848 shares at $75.2.
May 29 '24
JEFFS ROGER filed to sell 120,756 shares at $71.6.
March 15 '24

What is the Market Cap of Axsome Therapeutics?

The Market Cap of Axsome Therapeutics is $4.03B.

When does Axsome Therapeutics report earnings?

Axsome Therapeutics will report its next earnings on August 5 '24.

What is the current stock price of Axsome Therapeutics?

Currently, the price of one share of Axsome Therapeutics stock is $86.05.

How can I analyze the AXSM stock price chart for investment decisions?

The AXSM stock price chart above provides a comprehensive visual representation of Axsome Therapeutics' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Axsome Therapeutics shares. Our platform offers an up-to-date AXSM stock price chart, along with technical data analysis and alternative data insights.

Does AXSM offer dividends to its shareholders?

As of our latest update, Axsome Therapeutics (AXSM) does not offer dividends to its shareholders. Investors interested in Axsome Therapeutics should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Axsome Therapeutics?

Some of the similar stocks of Axsome Therapeutics are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.